Gordy, James T. http://orcid.org/0000-0003-2588-0756
Luo, Kun
Kapoor, Aakanksha
Kim, Emily S.
Ayeh, Samuel K.
Karakousis, Petros C.
Markham, Richard B. http://orcid.org/0000-0003-3527-9147
Article History
Received: 25 April 2019
Accepted: 31 December 2019
First Online: 24 January 2020
Compliance with ethical standards
:
: James T. Gordy and Richard B. Markham are inventors on pending patents using the vaccine platform described in this paper and have equity interest in a company that has rights to this vaccine platform. The authors declare that there is no other conflict of interest.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the IACUC of the Johns Hopkins University under Protocols #MO16H147 and MO19H139. This article does not contain any studies with human participants performed by any of the authors
: Not applicable.
: 5–6 week old female C57BL/6 (H-2b) mice were purchased from Charles River Laboratories (Wilmington, MA).
: Low-passage B16F10 cells were gifted to us by Dr. Jonathan Schneck (Johns Hopkins School of Medicine, Baltimore, MD). Cells were maintained with low passage stocks to maintain uniformity in transplantation, and therefore further authentication was deemed unnecessary.